Nurse-Led Psychoeducation for Caregivers Receiving Home Health Care (N-PRO CARE) (N-PRO CARE)

February 20, 2026 updated by: Sakine Firincik, Karabuk University

The Effect of a Nurse-Led Psychoeducation Programme for Caregivers of Patients Receiving Home Health Care on Self-Efficacy and Psychological Resilience: A Randomized Controlled Trial

This randomized controlled trial aimed to examine the effect of a nurse-led psychoeducation programme on self-efficacy and psychological resilience among caregivers of patients receiving home health care. Caregivers were randomly assigned to either an intervention group receiving a structured psychoeducation programme or a control group receiving usual care. Outcomes were assessed at baseline and one week after completion of the intervention using validated measurement tools.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Caregivers of patients receiving home health care often face physical, emotional, and psychosocial challenges that may negatively affect their well-being and caregiving capacity. Strengthening caregivers' psychological resources, such as self-efficacy and psychological resilience, is essential for improving both caregiver outcomes and the quality of care provided to patients.

This study was designed as a randomized controlled trial to evaluate the effectiveness of a structured, nurse-led psychoeducation programme delivered to caregivers of patients receiving home health care. A total of 42 caregivers were randomly allocated to an intervention group or a control group. The intervention group received a six-week psychoeducation programme consisting of weekly individual sessions lasting approximately 45 minutes, delivered in the home setting. The programme included education on caregiving skills, infection control, nutrition and mobilization, pressure injury prevention, urinary catheter care, as well as strategies to enhance self-efficacy and psychological resilience.

The control group received routine home health care services without additional psychoeducation. Data were collected using a Personal Information Form, the General Self-Efficacy Scale, and the Adult Psychological Resilience Scale at baseline and one week after completion of the intervention. The primary outcomes of the study were changes in caregivers' self-efficacy and psychological resilience levels following the psychoeducation programme.

Study Type

Interventional

Enrollment (Actual)

42

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey (Türkiye)
    • Amasra
      • Bartın, Amasra, Turkey (Türkiye), 74100
        • A State Hospital Home Health Care Unit

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Aged 18 years or older
  • Providing care to a patient receiving home health care for at least two months
  • Able to read and write
  • No communication barriers
  • Actively receiving home health care services for the patient
  • No diagnosed psychiatric disorder
  • Informal caregiver (not a formal caregiver such as a paid caregiver or nurse)
  • Willing to participate in the study and provide informed consent

Exclusion Criteria:

  • Formal caregivers (e.g., paid caregivers, nurses)
  • Individuals with communication impairments
  • Caregivers who did not meet the inclusion criteria
  • Withdrawal from the study during the intervention period

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Intervention Group (Nurse-Led Psychoeducation)
Caregivers assigned to the intervention group received a structured nurse-led psychoeducation programme in addition to usual home health care services.
Behavioral: Nurse-Led Psychoeducation Programme
The nurse-led psychoeducation programme was delivered individually to caregivers of patients receiving home health care. The programme consisted of six weekly sessions, each lasting approximately 45 minutes, conducted in the patient's home. The content included education and practical training on home health care services, infection control, nutrition and mobilization, pressure injury prevention, urinary catheter care, and strategies to enhance caregivers' self-efficacy and psychological resilience.
Other: Control Group (Usual Care)
Caregivers assigned to the control group received routine home health care services without any additional psychoeducation intervention.
Other: routine follow-up
the control group received usual care only

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Self-Efficacy
Time Frame: Baseline and 1 week after completion of the intervention
Self-efficacy levels of caregivers were assessed using the General Self-Efficacy Scale, a validated self-report instrument measuring individuals' perceived ability to cope with challenging situations.
Baseline and 1 week after completion of the intervention
Psychological Resilience
Time Frame: Baseline and 1 week after completion of the intervention
Psychological resilience levels of caregivers were assessed using the Adult Psychological Resilience Scale, a validated self-report instrument evaluating individuals' capacity to adapt positively to stress and adversity.
Baseline and 1 week after completion of the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Karabuk University

Investigators

  • Principal Investigator: Sakine Fırıncık, PhD, Karabuk University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

December 1, 2022

Primary Completion (Actual)

February 28, 2023

Study Completion (Actual)

February 28, 2023

Study Registration Dates

First Submitted

January 26, 2026

First Submitted That Met QC Criteria

February 20, 2026

First Posted (Actual)

February 25, 2026

Study Record Updates

Last Update Posted (Actual)

February 25, 2026

Last Update Submitted That Met QC Criteria

February 20, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 2022/1140
  • No secondary identifier assign (Other Identifier: No secondary identifier assigned)

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

For ethical reasons, individual patient data will not be shared.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Caregiver Burden

Clinical Trials on Nurse-Led Psychoeducation Programme

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Qatar

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe